Satol, Basit S.
HRN: 09-91-44 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2022
CEFTAZIDIME 1GM (VIAL)
04/25/2022
05/02/2022
IV
1g
Q8H
Pneumonia
Waiting Final Action
05/03/2022
CO-AMOXICLAV 625MG (TAB)
05/03/2022
05/10/2022
PO
625mg
TID
CAP-MR
Waiting Final Action